HUP9902188A2 - Természetes humán alfa-interferont tartalmazó gyógyszerkészítmények - Google Patents
Természetes humán alfa-interferont tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP9902188A2 HUP9902188A2 HU9902188A HUP9902188A HUP9902188A2 HU P9902188 A2 HUP9902188 A2 HU P9902188A2 HU 9902188 A HU9902188 A HU 9902188A HU P9902188 A HUP9902188 A HU P9902188A HU P9902188 A2 HUP9902188 A2 HU P9902188A2
- Authority
- HU
- Hungary
- Prior art keywords
- interferon
- natural human
- pharmaceutical compositions
- therapy
- administered
- Prior art date
Links
- 229940079322 interferon Drugs 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000004113 cell culture Methods 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 210000004698 lymphocyte Anatomy 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 206010019799 Hepatitis viral Diseases 0.000 abstract 1
- 241000282412 Homo Species 0.000 abstract 1
- 102000014150 Interferons Human genes 0.000 abstract 1
- 108010050904 Interferons Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000009826 neoplastic cell growth Effects 0.000 abstract 1
- 201000001862 viral hepatitis Diseases 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány tárgya limfőblaszt vagy leűkőcita sejtekből izőlálttermészetes hűmán a-interferőn alkalmazása 100-500 UI/nap dózisőkbanőrális beadásra szőlgáló főlyékőny gyógyszerkészítmény előállítására.A készítmények különösen hasznősak a vírűsős fertőzések, különösen avírűsős heptatitisz, neőplázia és imműnhiányős szindrómákgyógykezelésére. A találmány tővábbá természetes hűmán a-interferőnttartalmazó őrális beadásra szőlgáló főlyékőny gyógyszerkészítményre isvőnatkőzik. ŕ
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9902188A HUP9902188A3 (en) | 1997-02-27 | 1997-02-27 | Pharmaceutical compositions comprising natural human alfa-interferon |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9902188A HUP9902188A3 (en) | 1997-02-27 | 1997-02-27 | Pharmaceutical compositions comprising natural human alfa-interferon |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9902188A2 true HUP9902188A2 (hu) | 2000-01-28 |
| HUP9902188A3 HUP9902188A3 (en) | 2000-02-28 |
Family
ID=89998572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9902188A HUP9902188A3 (en) | 1997-02-27 | 1997-02-27 | Pharmaceutical compositions comprising natural human alfa-interferon |
Country Status (1)
| Country | Link |
|---|---|
| HU (1) | HUP9902188A3 (hu) |
-
1997
- 1997-02-27 HU HU9902188A patent/HUP9902188A3/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9902188A3 (en) | 2000-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0858343B1 (en) | Continuous low-dose cytokine infusion therapy | |
| EP0741577B1 (en) | The use of interferon subtype alpha 8 in the preparation of medicaments to treat viral infections of the liver | |
| CA2118121A1 (en) | Methods and compositions for the treatment of diseases with interferon while reducing side effects | |
| KR890700035A (ko) | 개량된 인터페론 요법 | |
| EP0107498A2 (en) | Synergistic human interferon activity | |
| SHALABY et al. | In vivo augmentation of natural killer activity by combined treatment with recombinant gamma interferon and interleukin-2 | |
| HUP9902188A2 (hu) | Természetes humán alfa-interferont tartalmazó gyógyszerkészítmények | |
| Borden et al. | Preclinical and clinical studies of interferons and interferon inducers in breast cancer | |
| IT1283945B1 (it) | Uso dell'interferone alfa naturale umano da cellule linfoblastoidi per la terapia delle epatiti virali, neoplasie e sindromi da | |
| IT1284852B1 (it) | Uso dell'interferone alfa naturale umano da cellule leucocitarie per la terapia delle epatiti virali, neoplasie e sindromi da | |
| DE69706657D1 (de) | Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen | |
| OA08768A (fr) | Traitement du virus su SIDA par l'interféron alpha humain recombinant. | |
| Cantell | Towards the clinical use of interferon | |
| MY119359A (en) | Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis. | |
| Sanders et al. | Immune-associated toxicities induced by in vivo and in vitro exposure to interferon-alpha alone or in combination with nucleoside analogs | |
| Folkers | Antiretrovirals plus immunomodulators: didanosine/interferon-alpha combination shows promise | |
| CA2495480A1 (en) | Interferon and immunoglobulin fc fragment hybrid | |
| RU93041496A (ru) | γ -РL/ГАММА-ПЛАНТ/-ИНТЕРФЕРОНИНДУЦИРУЮЩЕЕ СРЕДСТВО |